Arek Kendirli

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 8

Top Topics

Subarachnoid Hemorrhage

Spinal Cord Injury

Top Venues

EMBO molecular medicine

Nature metabolism

Nature neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Arek Kendirli, Clara de la Rosa, Katrin F Lämmle, Klara Eglseer, Isabel J Bauer, Vladyslav Kavaka, Stephan Winklmeier, La Zhuo, Christian Wichmann, Lisa Ann Gerdes, Tania Kümpfel, Klaus Dornmair, Eduardo Beltrán, Martin Kerschensteiner, Naoto Kawakami
A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model. Nature neuroscience (2023)
Almir Aljović, Anne Jacobi, Maite Marcantoni, Fritz Kagerer, Kristina Loy, Arek Kendirli, Jonas Bräutigam, Luca Fabbio, Valerie Van Steenbergen, Katarzyna Pleśniar, Martin Kerschensteiner, Florence M Bareyre
Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury. EMBO molecular medicine 15 (2) (2023)
Almir Aljović, Anne Jacobi, Maite Marcantoni, Fritz Kagerer, Kristina Loy, Arek Kendirli, Jonas Bräutigam, Luca Fabbio, Valerie Van Steenbergen, Katarzyna Pleśniar, Martin Kerschensteiner, Florence M Bareyre
Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury. EMBO molecular medicine 15 (2) (2023)
Almir Aljović, Anne Jacobi, Maite Marcantoni, Fritz Kagerer, Kristina Loy, Arek Kendirli, Jonas Bräutigam, Luca Fabbio, Valerie Van Steenbergen, Katarzyna Pleśniar, Martin Kerschensteiner, Florence M Bareyre
Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury. EMBO molecular medicine 15 (2) (2023)
Almir Aljović, Anne Jacobi, Maite Marcantoni, Fritz Kagerer, Kristina Loy, Arek Kendirli, Jonas Bräutigam, Luca Fabbio, Valerie Van Steenbergen, Katarzyna Pleśniar, Martin Kerschensteiner, Florence M Bareyre
Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury. EMBO molecular medicine (2023)
Almir Aljović, Anne Jacobi, Maite Marcantoni, Fritz Kagerer, Kristina Loy, Arek Kendirli, Jonas Bräutigam, Luca Fabbio, Valerie Van Steenbergen, Katarzyna Pleśniar, Martin Kerschensteiner, Florence M Bareyre
Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury. EMBO molecular medicine 15 (2) (2023)
Yi-Heng Tai, Daniel Engels, Giuseppe Locatelli, Ioanna Emmanouilidis, Caroline Fecher, Delphine Theodorou, Stephan A Müller, Simon Licht-Mayer, Mario Kreutzfeldt, Ingrid Wagner, Natalia Prudente de Mello, Sofia-Natsouko Gkotzamani, Laura Trovò, Arek Kendirli, Almir Aljović, Michael O Breckwoldt, Ronald Naumann, Florence M Bareyre, Fabiana Perocchi, Don Mahad, Doron Merkler, Stefan F Lichtenthaler, Martin Kerschensteiner, Thomas Misgeld
Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesions. Nature metabolism (2023)
Almir Aljović, Anne Jacobi, Maite Marcantoni, Fritz Kagerer, Kristina Loy, Arek Kendirli, Jonas Bräutigam, Luca Fabbio, Valerie Van Steenbergen, Katarzyna Pleśniar, Martin Kerschensteiner, Florence M Bareyre
Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury. EMBO molecular medicine 15 (2) (2023)